HCPCS Code Detail Logo

HCPCS Codes Similar to G0462

HCPCS Codes Similar to “G0462” Code.
Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)

G0461
Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain
Code added date: 20140101
Code effective date: 20150101
L5616
Addition to lower extremity, endoskeletal system, above knee, universal multiplex system, friction swing phase control
Code added date: 19860101
Code effective date: 19960101
M1193
Surgical pathology reports that contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both
Code added date: 20230101
Code effective date: 20230101
M1194
Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)
Code added date: 20230101
Code effective date: 20230101
M1195
Surgical pathology reports that do not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both, reason not given
Code added date: 20230101
Code effective date: 20230101
G0298
Hiv antigen/antibody, combination assay, screening
Code added date: 20150413
Code effective date: 20150413
M0235
Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose
Code added date: 20251001
Code effective date: 20251001
M0236
Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose
Code added date: 20251001
Code effective date: 20251001
Q0235
Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg
Code added date: 20251001
Code effective date: 20251001
S9562
Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
Code added date: 20030101
Code effective date: 20230401
G9202
Patients with a positive hepatitis c antibody test
Code added date: 20140101
Code effective date: 20150101
G9452
Documentation of medical reason(s) for not receiving hcv antibody test due to limited life expectancy
Code added date: 20150101
Code effective date: 20240101
G9839
Anti-egfr monoclonal antibody therapy
Code added date: 20170101
Code effective date: 20170101
G9844
Patient did not receive anti-egfr monoclonal antibody therapy
Code added date: 20170101
Code effective date: 20170101